These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of imported New World cutaneous leishmaniasis in Germany. Harms G; Scherbaum H; Reiter-Owona I; Stich A; Richter J Int J Dermatol; 2011 Nov; 50(11):1336-1342. PubMed ID: 22004484 [TBL] [Abstract][Full Text] [Related]
3. Case Report: Miltefosine Failure and Spontaneous Resolution of Cutaneous Leishmaniasis braziliensis. Joseph S; Whitman TJ; Buckner FS; Cogen AL Am J Trop Med Hyg; 2021 May; 105(1):142-143. PubMed ID: 33970891 [TBL] [Abstract][Full Text] [Related]
4. Mucosal relapse one year after complete remission of cutaneous sporotrichoid leishmaniasis due to Leishmania braziliensis. Ntasou AA; Grummich H; Fischer K; Baur V; Bonkowsky V; Birkmann J; Schultz ES Eur J Dermatol; 2016; 26(1):94-5. PubMed ID: 26462596 [No Abstract] [Full Text] [Related]
5. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome. Coelho AC; Oliveira JC; Espada CR; Reimão JQ; Trinconi CT; Uliana SR PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739 [TBL] [Abstract][Full Text] [Related]
6. [Leishmania braziliensis: report of a pediatric imported case with response to liposomal amphotericin B]. Campos-Muñoz L; Quesada-Cortés A; Martín-Díaz MA; Rubio-Flores C; de Lucas-Laguna R Actas Dermosifiliogr; 2007; 98(1):42-4. PubMed ID: 17374332 [TBL] [Abstract][Full Text] [Related]
7. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis. Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541 [TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers. Solomon M; Pavlotzky F; Barzilai A; Schwartz E J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous leishmaniasis treatment. Minodier P; Parola P Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941 [TBL] [Abstract][Full Text] [Related]
10. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil. Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease. Mings S; Beck JC; Davidson C; Ondo AL; Shanler SD; Berman J Am J Trop Med Hyg; 2009 Jan; 80(1):3-5. PubMed ID: 19141829 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415 [TBL] [Abstract][Full Text] [Related]
13. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis. Crone CG; Helleberg M J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570 [No Abstract] [Full Text] [Related]
15. Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report. Ramesh V; Avishek K; Sharma V; Salotra P Acta Derm Venereol; 2014 Mar; 94(2):242-3. PubMed ID: 23995012 [No Abstract] [Full Text] [Related]
16. Oral miltefosine to treat new world cutaneous leishmaniasis. Soto J; Toledo JT Lancet Infect Dis; 2007 Jan; 7(1):7. PubMed ID: 17182338 [No Abstract] [Full Text] [Related]
17. Atypical mucocutaneous involvement with Leishmania donovani. Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292 [TBL] [Abstract][Full Text] [Related]
18. Miltefosine Combined with Intralesional Pentamidine for Soto J; Soto P; Ajata A; Rivero D; Luque C; Tintaya C; Berman J Am J Trop Med Hyg; 2018 Nov; 99(5):1153-1155. PubMed ID: 30255833 [TBL] [Abstract][Full Text] [Related]
19. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Brown M; Noursadeghi M; Boyle J; Davidson RN Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352 [TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Disseminated Cutaneous Leishmaniasis With Liposomal Amphotericin B and Miltefosine in an Eight-year-old Girl. Hamzavi SS; Sanaei Dashti A; Kadivar MR; Pouladfar G; Pourabbas B Pediatr Infect Dis J; 2018 Mar; 37(3):275-277. PubMed ID: 29424815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]